Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Vincenti

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
British Journal of Clinical Pharmacology|June 9, 2007
Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patientsMark D Pescovitz, Flavio Vincenti, Marquis Hart, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 17, 2011
Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetesLionel Rostaing, Hans H Neumayer, Rafael Reyes-Acevedo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 20, 2003
Prevalence and management of anemia in renal transplant recipients: a European surveyYves Vanrenterghem, Claudio Ponticelli, José Maria Morales, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 28, 2016
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized TrialJosep M Grinyó, Maria Del Carmen Rial, Josefina Alberu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 31, 2020
Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipientsAllan D Kirk, Andrew B Adams, Antoine Durrbach, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 22, 2012
Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipientsQizhi Tang, Joey Leung, Kristin Melli, et al.
Contributions to Nephrology|April 11, 2008
Proteomics of plasma and urine in primary nephrotic syndrome in childrenGiovanni Candiano, Luca Musante, Andrea Petretto, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 1, 2008
Association of four DNA polymorphisms with acute rejection after kidney transplantationJosep Grinyó, Yves Vanrenterghem, Björn Nashan, et al.
Transplantation|November 20, 2010
An integrated safety profile analysis of belatacept in kidney transplant recipientsJosep Grinyó, Bernard Charpentier, José Medina Pestana, et al.
Annals of Translational Medicine|July 5, 2023
Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factorsPriyanka Rashmi, Tara K Sigdel, Dmitry Rychkov, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
British Journal of Clinical Pharmacology|June 9, 2007
Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patientsMark D Pescovitz, Flavio Vincenti, Marquis Hart, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 17, 2011
Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetesLionel Rostaing, Hans H Neumayer, Rafael Reyes-Acevedo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 20, 2003
Prevalence and management of anemia in renal transplant recipients: a European surveyYves Vanrenterghem, Claudio Ponticelli, José Maria Morales, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 28, 2016
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized TrialJosep M Grinyó, Maria Del Carmen Rial, Josefina Alberu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 31, 2020
Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipientsAllan D Kirk, Andrew B Adams, Antoine Durrbach, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|September 22, 2012
Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipientsQizhi Tang, Joey Leung, Kristin Melli, et al.
Contributions to Nephrology|April 11, 2008
Proteomics of plasma and urine in primary nephrotic syndrome in childrenGiovanni Candiano, Luca Musante, Andrea Petretto, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 1, 2008
Association of four DNA polymorphisms with acute rejection after kidney transplantationJosep Grinyó, Yves Vanrenterghem, Björn Nashan, et al.
Transplantation|November 20, 2010
An integrated safety profile analysis of belatacept in kidney transplant recipientsJosep Grinyó, Bernard Charpentier, José Medina Pestana, et al.
Annals of Translational Medicine|July 5, 2023
Perturbations in podocyte transcriptome and biological pathways induced by FSGS associated circulating factorsPriyanka Rashmi, Tara K Sigdel, Dmitry Rychkov, et al.
Pageof 12